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Duchenne muscular dystrophy (DMD) is one of the mortal diseases, 
subjected to study in terms of molecular investigation. In this study, the 
protein interaction map of this muscle-wasting condition was generated to 
gain a better knowledge of interactome profile of DMD.
Materials & Methods
 Applying Cytoscape and String Database, the protein-protein interaction 
network was constructed and the gene ontology of the constructed network 
was analyzed for biological process, molecular function, and cellular 
component annotations. 
Results
Among 100 proteins related to DMD, dystrophin, utrophin, caveolin 3, and 
myogenic differentiation 1 play key roles in DMD network. In addition, the 
gene ontology analysis showed that regulation processes, kinase activity, 
and sarcoplasmic reticulum were the highlighted biological processes, 
molecular function, and cell component enrichments respectively for the 
proteins related to DMD. 
Conclusion
The central proteins and the enriched ontologies can be suggested as 
possible prominent agents in DMD; however, the validation studies may 
be required.
Keywords: Duchenne muscular dystrophy (DMD); Protein-protein 
interaction network; Gene ontology; Hub-bottlenecks; Biomarker panel 
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Introduction 
Duchenne muscular dystrophy (DMD) is a severe muscle degradation condition 
that consequent in death of the patient. This inheritable disease is common in males 
with the prevalence of 1 out of 3500 (1). A functional neural deficit in this disease 
is reported. However, there are some ethical problems for investigation on the sick 
boys; EEG abnormality is reported for the number of the patients (2). There is not 
yet a suitable treatment for DMD (3). 
There are some molecular studies for DMD (4, 5). One of the main extensively 
changed expressed molecules in this disease is known as dystrophin protein that 
the lack of its gene expression is linked to the disease development (6). This protein 
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Cytoscape can provide different interaction data from 
different sources. One of them, as mentioned earlier, 
is the String DB (http://string-db.org/) (12, 13). It has three 
options for retrieving interaction data including PubMed, 
disease, and proteins queries. 
Protein interaction map was constructed according to 
String Database criteria. Here, the disease query was 
used for extracting 100 top related proteins to DMD. 
The used cut off for interaction evidence was set at 0.5. 
This score is a combined score from different sources. 
The disease score shows the relation of the disease and 
the obtained proteins. String DB provides interaction 
information from different sources. Furthermore, for 
network centrality analysis, Network Analyzer can 
be used. Here, the examined centrality parameters are 
degree and betweenness centrality. The nodes with 
highest degree (connections) are known as hub nodes 
and similarly, the nodes based on a function of larger 
number of shortest paths passing through them are called 
bottlenecks (14). These elements are crucial for the 
disease onset and progress (15). 
Gene ontology analysis of the whole components of the 
network was done by the application of The Database 
for Annotation, Visualization and Integrated Discovery 
(DAVID) Bioinformatics 6.8 (http://david.niaid.nih.gov). The 
ontology analysis was based on biological process (BP), 
cellular component (CC), and molecular function (MF). 
The associated proteins were clustered for each of these 
annotations. In each cluster, similar enrichments are 
included (16). DAVID uses kappa statistics to group the 
terms. 
Results
The protein network was constructed from 100 nodes 
including 18 isolated nodes and 1 main connected 
component. The network (main connected component) 
contains 82 nodes with different disease score relations 
and 395 edges. The highest disease combined score [4] 
was assigned for dystrophin protein. This protein also 
showed the highest value in degree (Figure 1). 
can cause vast amount of changes in morphology and 
function of skeletal muscle tissue (5). Therefore, it 
accounts as putative biomarker for DMD. Beside 
important role of dystrophin, there are other introduced 
proteins for DMD, mostly conducted by proteomic 
approaches (7, 8). 
Understanding other related proteins can help for better 
understanding and managing the disease. In addition to 
the role of these proteins, the interaction pattern of them 
can add more information about their contribution in 
DMD (9). Consequently, protein interaction networks 
provide information related to systematic communication 
scale of different kinds of diseases. Proteins that are 
dysfunctional in a specific disease condition are in 
complex interactions with each other. Dysregulation of 
each of these components can induce modification of 
the interaction of the whole interactome and changes 
the functions of other proteins. These disruptions of the 
whole system are responsible for the abnormal phenotype 
such as diseases (10). Some modification can be referred 
to the proteins that are essential for an interacted system 
(11). These proteins are known as central components 
that their dysfunctions lead to massive changes in the 
interaction profile (10). Therefore, detecting topological 
features can be prominent for disease analysis in terms 
of molecular origin (9). Here for obtaining a better 
knowledge about molecular mechanisms of DMD, 
the protein interactome and gene ontology analysis of 
disease was conducted usingf Cytoscape and DAVID 
software, respectively. 
Materials and Methods
Determination of related proteins to a certain disease 
can be handled through different sources. One of the 
important sources is Cytoscape 3.4. This common 
software is free and is compatible with different sources. 
Many applications are available via Cytoscape and can 
provide further information for the mapped network. 
One of the famous interaction sources is String Database 
(DB). It is accessible through Cytoscape software. 
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differentiation-1 are hub-bottleneck proteins (Table 1). 
Since connection between the determined crucial nodes 
provides informative data, these findings are tabulated 
in Table 2.
The centrality analysis of the network components based 
on selection of top 5% of the hub nodes and cut off 
0.05 for betweenness revealed that 4 proteins including 
dystrophin, utrophin, caveolin-3 and myogenic 
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Fig 1. The protein-protein interaction mapping of DMD after analysis with network analyzer, as the nodes get bigger, 
the degree increases. The network (main connected component) consists of 82 nodes and 395 edges.
Table 1. The list of hub-bottleneck nodes of DMD PPI network based on degree and betweenness centrality analysis 
Gene name Description Degree BC Disease score
DMD Dystrophin 40 0.4 4
UTRN Utrophin 28 0.1 3.9
CAV3 Caveolin 3 19 0.05 2
MYOD1 Myogenic differentiation 1 19 0.1 2.3
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DAVID Bioinformatics Resources 6.8 (16), applied for 
functional annotation of the all contributed proteins in 
DMD network including biological process (BP), cell 
component (CC), and molecular function (MF) (Table 
3,4). Each of abbreviations refers to the certain operation 
Duchenne Muscular Dystrophy (DMD) Protein-Protein Interaction Mapping
Table 2. Interactions properties between the determined hub-bottleneck nodes. The combined score was set to 0.5. 
There is no interaction between CAV3 and MYOD1 (16)
Interactions Combined Score
CAV3 (pp) DMD 0.992
DMD (pp) UTRN 0.964
MYOD1 (pp) DMD 0.815
CAV3 (pp) UTRN 0.699
MYOD1 (pp)UTRN 0.724
for example “RT” (related term) refers to the terms 
related to the main introduced term in the same row. The 
accepted P-value is 0.1 and the terms are sorted base on 
P-value amounts. Enrichment score corresponds to the 
important role of the introduced terms in the cluster.
Table 3. Clustering annotation of the contributing elements in DMD network based on BP analysis. Benjamini–
Hochberg is the correction method for P value
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Table 5. Clustering annotation of the contributing elements in DMD network based on MF analysis. Benjamini–
Hochberg is the correction method for P-value.
Duchenne Muscular Dystrophy (DMD) Protein-Protein Interaction Mapping
Table 4. Clustering annotation of the contributing elements in DMD network based on CC analysis. Benjamini–
Hochberg is the correction method for P-value
Discussion
Protein interaction mapping as a powerful analytical 
method is attracted a great attention of scientists in the 
field of molecular analysis of diseases (17). One of the 
recently introduced disciplines is network medicine that 
investigates about network topological features of a 
specific disease (18). The information which introduces 
numbers of essential proteins in terms of interactions can 
be crucial in disease progression (19). These proteins 
can be considered as biomarkers that by validation tests 
would be introduced for clinical approaches. 
The aim of this study was to provide a preliminary 
knowledge of these key components for more in depth 
comprehension of Duchenne muscular dystrophy related 
mechanisms and further investigation in this field. 
Consequently, a network of all 100 top reported proteins 
for this disease was constructed and analyzed based on 
centrality and gene ontology. The associated proteins 
for this disease were obtained from String source and 
this source assigned disease score relation based on 
differently combined evidence. Only 82 genes included 
in the network and the numbers of 18 genes remained 
isolated. Each node is connected to the about 5 neighbor 
nodes. However, due to heterogeneity of the network, 
the number of the edges for the nodes is different. The 
centrality analysis of the illustrated network differentiated 
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the nodes and the important genes were highlighted. 
The important proteins are visible as the largest nodes 
in the network. Network Analyzer is the applied plug-in 
for this analysis, provide quantitative information. We 
choose the most ranked proteins according to the highest 
degree and largest betweenness centrality. The proteins 
that showed both characteristics are listed in Table 1. 
They are known as hub-bottleneck proteins (18). Hub 
implies on high degree and equally, bottlenecks denote 
large BC values (20). Therefore, these four proteins 
including dystrophin, utrophin, caveolin 3, and myogenic 
differentiation-1 are the key agents of the DMD network. 
Dystrophin as the putative biomarker of DMD (21), 
also express high centrality values in our network. 
Attributing top score to dystrophin in our research is a 
potent validation for the constructed and analyzed PPI 
network related to DMD. This protein is the top rated 
node for the integrity of the network. About 10% of all 
edges are linked to this protein connected to the 50% 
of all nodes of the network. Dystrophin is characterized 
by top scores of degree; betweenness and disease score 
(Table 1). Other key proteins are also important and their 
role needs more evaluation in the disease. In fact, their 
involvement with different expression changes has been 
reported extensively for DMD (3, 22, 23). 
Utrophin the second key protein in our analysis possess 
near scores to dystrophin in compare to the other two 
proteins. Its disease score is equal to Utrophin so it is 
related to DMD strongly. For more resolution, mutual 
interaction between the crucial proteins as a useful tool 
was done. In Table 2, the linkage of theses essential 
proteins together is tabulated. The interactions scores 
show that the proteins have high degree of interactions 
between each other. However, only CAV3 and MYOD1 
have no connections. The introduced central proteins 
construct an integrated network related to DMD. 
Combined score value for the paired genes is higher if 
DMD is paired. On the other hand, MYOD1 reduces 
this score. This finding confirms the order of the sorted 
genes. 
Moreover, to identify the role of these linked proteins to 
the disease, the gene ontology analysis was used. All the 
extracted proteins [82] were under consideration of this 
purpose as they show some association to the disease. 
Accordingly, DAVID Bioinformatics clustered these 
agents with the respect to query annotations. The ontology 
aspects include BP, CC, and MF. The first implemented 
ontology is biological process of the DMD relevant 
proteins. In each enrichment analysis, two important 
clusters are introduced. The first one is the significant 
cluster and the related terms in this cluster may play 
more roles that are important in DMD. The main terms 
in cluster 1 are the biological processes are most active 
in regulatory processes. Muscle cell fate commitment 
is the most significant term with the contribution of 4 
of the proteins in the network. Skeletal muscle tissue 
development, positive regulation of skeletal muscle fiber 
development, positive regulation of myoblast fusion, 
positive regulation of myoblast differentiation, positive 
regulation of muscle cell differentiation, skeletal muscle 
cell differentiation is the other terms related to the 
involved proteins in DMD. In cell component analysis, 
the sarcoplasmic reticulum is the proposed resident for 
the most of the DMD proteins, in which sarcoplasmic 
reticulum membrane is the most significant part. T tubule 
and I band are the other two components determined as 
related parts to the DMD. DAVID functional annotation 
for MF in Table 5 showed that kinase activity is the 
highlighted function of the DMD network and creatine 
kinase activity is the most highlighted one. ATP binding 
is the other molecular function attributed to the analyzed 
proteins of DMD PPI network. Investigation about 
roles of dystrophin (24), utrophin (25), caveolin-3 
(26), and myogenic differentiation-1 (27) indicates that 
relationship between cluster-1 and DMD is highlighted; 
terms of cluster-1 play roles that are more important in 
DMD relative to cluster-2.
In Conclusion, dystrophin, utrophin, caveolin 3, and 
myogenic differentiation-1 are introduced as biomarker 
panel for DMD onset and development. However, the 
first two proteins play crucial roles. More investigation 
in the field can lead to validation of the elements of this 
panel for diagnostic and therapeutic proposes. 
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